Atomwise vs MOMA Therapeutics
MOMA Therapeutics
Independently Excellent. Collectively Unstoppable
42 employees · est. 2020 · Cambridge, United States
Atomwise is the older company (2012 vs 2020).
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Atomwise | MOMA Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2012 older | 2020 |
| Headquarters | ||
| Headquarters | San Francisco, United States | Cambridge, United States |
| Employees | ||
| Employees | 13 | 42 |
| Industry | ||
| Industry | AI, Biotechnology, Health Care | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Grant | Series B |
| Total Funding | ||
| Total Funding | $176.65M | $236.00M |
| Funding Rounds | ||
| Funding Rounds | 9 | 2 |
| Services | ||
| Services | AI-based drug discovery, Immune and inflammatory disease therapeutics, Chemical space exploration | Discovering Precision Medicines, Targeting Molecular Machines, Drug Development Pipeline |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Biotechnology firms, Medical researchers, Healthcare providers | Patients with Specific Diseases, Healthcare Providers, Pharmaceutical Companies, Research Institutions |
| Taxonomy | ||
| Taxonomy | AI Drug DiscoveryDeep LearningStructure-Based Drug DiscoverySmall-Molecule Drug CandidatesPreclinical StudiesUndruggable Targets +8 | Precision MedicineClinical-Stage BiotechnologyDynamic Proteins TargetingSmall Molecule ApproachKNOMATIC PlatformProtein Conformation +6 |
| Website | ||
| Website | atomwise.com | momatx.com |
About Atomwise
Atomwise, founded in 2012, is a pioneering preclinical pharma company based in the United States. Operating at the intersection of AI, Biotechnology, and Health Care, it aims to deliver on its slogan: Better Medicines Faster. The company has set a milestone by expanding its Board of Directors and c...
About MOMA Therapeutics
MOMA Therapeutics, founded in 2020 and headquartered in the United States, is a clinical-stage, precision medicine startup with a resolute focus on targeting dynamic proteins responsible for human diseases. Through its proprietary KNOMATIC platform, MOMA seeks to innovate the small molecule approach...
Also comparing in this category
Comparing more than these two?
Get Atomwise, MOMA Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Atomwise compare?
A PDF of Atomwise and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Atomwise with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Atomwise on 21 Sep 2026, and MOMA Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.